Rozanolixizumab

• Description :

  Rozanolixizumab (UCB7665), a humanized high-affinity anti-human neonatal Fc receptor (FcRn) monoclonal antibody (IgG4P), is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases[1].

• Product Name Alternative :

  UCB7665

• UNSPSC :

  12352203

• Target :

  TNF Receptor

• Type :

  Inhibitory Antibodies

• Related Pathways :

  Apoptosis

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/rozanolixizumab.html

• Purity :

  99.40

• Solubility :

  H2O

• Smiles :

  [Rozanolixizumab]

• Molecular Weight :

  (145.242 kDa)

• References & Citations :

  [1]Smith B, et al. Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration. MAbs. 2018;10 (7) :1111-1130.

• Shipping Conditions :

  Dry Ice

• Storage Conditions :

  Store at -80°C for 2 years

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  Launched

• CAS Number :

  [1584645-37-3]